Skip to main content
Neurology logoLink to Neurology
. 2013 Nov 26;81(22):1966. doi: 10.1212/01.wnl.0000436079.95856.1f

Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution

Ilya Kister 1, Yulin Ge 1, Joseph Herbert 1, Tim Sinnecker 2, Jens Wuerfel 2, Friedemann Paul 2
PMCID: PMC10664739  PMID: 24276335

Editors' Note: In response to an inquiry by Drs. Lerner and Miodownik, American Academy of Neurology (AAN) guideline authors Bhidayasiri et al. discuss how relevant studies are analyzed and classified for potential inclusion in AAN practice guidelines. The painstaking process used in the development of AAN practice guidelines is described in detail in the Clinical Practice Guideline Process Manual (http://tools.aan.com/globals/axon/assets/9023.pdf) available to AAN members and the public on the AAN Web site. —Megan Alcauskas, MD, and Robert C. Griggs, MD

Matthews et al.1 attempted to differentiate seropositive neuromyelitis optica spectrum disorders (NMOSD) from multiple sclerosis (MS) based on brain MRI records. They suggested that none of the patients with NMOSD exhibited “Dawson fingers” on brain MRI.

James Dawson described these characteristic lesions in MS pathologically as “wedge-shaped areas with broad base to the ventricle, and extensions into adjoining tissue in the form of finger-like processes or ampullae, in each of which a central vessel could usually be found.”2 Ultra-high-field MRI allows for in vivo visualization of small central veins within Dawson fingers.

Our 2 groups used ultra-high-field MRI to image brains in NMOSD and MS and independently reported that periventricular lesions are rare in NMOSD and lack central venule.3,4 This supports the authors' finding that the presence of Dawson fingers constitutes strong evidence against the diagnosis of NMOSD. However, for this criterion to be useful in clinical practice, an unambiguous definition of what constitutes Dawson finger on conventional brain MRI must be adopted.

It would be helpful if the authors could supply a definition based on their experience with NMOSD and MS that would more formally specify lesion morphology. This should include details on borders, dimensions, and orientation on axial and sagittal T2-weighted sequences. In addition, a defined distance from lateral ventricles and other periventricular lesions would be helpful.

References

  • 1.Matthews L, Marasco R, Jenkinson M, et al. Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurology 2013;80:1330–1337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Dawson JW. The histology of disseminated sclerosis. Trans R Soc Edinb 1916;50:621. [Google Scholar]
  • 3.Sinnecker T, Dorr J, Pfueller CF, et al. Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis. Neurology 2012;79:708–714. [DOI] [PubMed] [Google Scholar]
  • 4.Kister I, Herbert J, Zhou Y, Ge Y. Ultrahigh-field MR (7 T) imaging of brain lesions in neuromyelitis optica. Mult Scler Int 2013;2013:398259. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Neurology are provided here courtesy of American Academy of Neurology

RESOURCES